- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT06886815
Bloc du nerf poplitéal pour la chirurgie de réparation du tendon d'Achille
L'effet du bloc nerveux poplitéal sur la récupération après la chirurgie de réparation du tendon d'Achille: un essai contrôlé randomisé
Achilles tendon rupture is common, yet the value of popliteal nerve block for postoperative pain control during surgical repair remains uncertain. Despite widespread use, evidence supporting its analgesic effectiveness is limited, and both popliteal nerve block and Achilles tendon repair carry risks of nerve injury. This randomized, placebo-controlled trial will evaluate whether adding a popliteal nerve block to standard systemic analgesia improves postoperative pain and reduces opioid use in patients undergoing acute Achilles tendon rupture repair. Secondary outcomes will examine the incidence and impact of nerve complications on recovery, including return to physical activity and functional performance.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
This will be a prospective, double-blinded, randomized controlled superiority trial conducted at Women's College Hospital (WCH). The study aims to enroll 80 patients (40 per group) undergoing ambulatory surgical repair of acute Achilles tendon ruptures.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Didem Bozak
- Numéro de téléphone: 416-323-6008
- E-mail: didem.bozak@wchospital.ca
Lieux d'étude
-
-
Ontario
-
Toronto, Ontario, Canada, M5S 1B2
- Recrutement
- Women's College Hospital
-
Chercheur principal:
- Richard Brull, MD,FRCPC
-
Contact:
- Didem Bozak
- Numéro de téléphone: 416-323-6008
- E-mail: didem.bozak@wchospital.ca
-
Sous-enquêteur:
- Connor TA Brenna, MD
-
Sous-enquêteur:
- Seung C Kim, MD,FFPMRCA
-
Sous-enquêteur:
- Faraj W Abdallah, MD,FRCPC
-
Sous-enquêteur:
- Sam Park, MD,MASc
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Age 18 - 65
- ASA classification: I - III
- BMI < 35 kg/m2
- Undergoing acute Achilles tendon rupture repair surgery as a day surgery procedure
Exclusion Criteria:
- Pre-existing neurological deficits or peripheral neuropathy in the distribution of the tibial or common peroneal nerves
- Local infection
- Contraindication to regional anesthesia (e.g., bleeding diathesis, coagulopathy)
- History of use of over 30 mg oxycodone or equivalent per day
- Contraindication to any component of a standard multi-modal analgesia
- Allergy to local anesthetics
- History of significant psychiatric conditions that may affect patient assessment
- Pregnancy
- Inability to provide informed consent
- Patient refusal of popliteal nerve blockade
- Prior Achilles tendon surgeries on the operative leg
- Unable to speak or read English
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Tripler
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Popliteal nerve (PN) block group
30 mL of 0.5% ropivacaine with 2.5 µg/ml of epinephrine |
Under ultrasound guidance, a 22G, 80-mm echogenic needle (SonoTAP II, Pajunk Medical Systems, USA) will be inserted using an in-plane lateral-to-medial approach. 30 mL of 0.5% ropivacaine with 2.5 µg/ml of epinephrine will be deposited between tibial and common peroneal nerves within the paraneural sheath. Adequate spread of local anesthetics will be confirmed by visualization of paraneural spread.
Autres noms:
|
|
Comparateur factice: Placebo Nerve Block
1 mL of saline |
Patients in the Control group will receive sham blocks using a 25G needle to inject 1 mL of saline subcutaneously in the same location (popliteus of the surgical knee). Sterilization and ultrasound scanning will match actual PN block. Such a non-invasive placebo allows maintaining patient blinding, while reducing the risks associated with high-volume placebo nerve block injections. The ultrasound screen will be blinded from the patient's vision for all patients in the trial to prevent unblinding by patients with knowledge of the technique. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Cumulative Opioid Consumption
Délai: The first 24 hours after surgery
|
Total opioid dose administered to each patient, converted to oral morphine equivalents. |
The first 24 hours after surgery
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Area Under the Curve for Postoperative Pain
Délai: The first 24 hours after surgery
|
Area under the curve calculated from discrete Numeric Rating Scale evaluations of postoperative pain (0 - 10), where 0 corresponds to no pain, and 10 corresponds to the worst pain imaginable. Pain will be measured on this scale at 0, 6, 12, 18, and 24 hours after surgery. |
The first 24 hours after surgery
|
|
Quality of Recovery
Délai: At baseline, 6, 24, 48 hours, 7 days and 1-year post-surgery
|
Quality of recovery evaluated using the QoR-15 scale (0 - 150), where 0 represents extremely poor recovery and 150 represents excellent recovery. |
At baseline, 6, 24, 48 hours, 7 days and 1-year post-surgery
|
|
Postoperative Pain Score
Délai: At baseline, 0, 6, 12, 18, 24, 36, 48 hours, 7 days and 1-year post-surgery.
|
Measured using the Numeric Rating (NRS) Scale (0 - 10) where 0 corresponds to no pain, and 10 corresponds to the worst pain imaginable. |
At baseline, 0, 6, 12, 18, 24, 36, 48 hours, 7 days and 1-year post-surgery.
|
|
Intraoperative Opioid Consumption
Délai: The first 24 hours after surgery
|
Measurement of opioids administered during surgery, converted into oral morphine equivalents. |
The first 24 hours after surgery
|
|
Time to Analgesic Request
Délai: The first 24 hours after surgery
|
Length of time until the patient's first request for analgesics following surgery. |
The first 24 hours after surgery
|
|
Time to Discharge
Délai: The first 24 hours after surgery
|
The length of time each patient stays in Phase I (Postanesthesia Care Unit) and Phase II (Surgical Day Care) after surgery. |
The first 24 hours after surgery
|
|
Adverse Events Attributable to Popliteal Block
Délai: At 0, 6, 12, 18, 24, 36, 48 hours, 7 days and 1-year post-surgery
|
The incidence of adverse events possibly attributable to popliteal nerve block, including peripheral nerve injury, hematoma, and infection. |
At 0, 6, 12, 18, 24, 36, 48 hours, 7 days and 1-year post-surgery
|
|
Adverse Events Attributable to Opioids
Délai: Evaluated at 24 and 48 hours after surgery.
|
The incidence of opioid-related side effects, including sedation, pruritis, nausea/vomiting, and respiratory depression. |
Evaluated at 24 and 48 hours after surgery.
|
|
Pain, fatigue, and physical function
Délai: Prior to surgery and 1-year post-surgery
|
Measured using the Achilles tendon Total Rupture Score (ATRS) |
Prior to surgery and 1-year post-surgery
|
|
Neuropathic pain
Délai: At 1 week and 1-year post-surgery
|
Measured using the English version of the Douleur Neuropathique 4 (DN4) Questionnaire |
At 1 week and 1-year post-surgery
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Richard Brull, MD, FRCPC, University Health Network, Toronto
Publications et liens utiles
Publications générales
- Brenna CTA, Khan S, Abdallah FW, Brull R. Achilles Hero or Heel? A Systematic Review of Popliteal Nerve Block for Achilles Repair. Foot & Ankle Surgery: Techniques, Reports & Cases. 2025:100474.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- 2025-0039-B
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .